查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678709

細胞治療技術市場規模、佔有率、趨勢分析報告：按產品類型、工作流程、細胞類型、最終用途、地區和細分市場進行預測，2025 年至 2030 年

Cell Therapy Technologies Market Size, Share & Trends Analysis Report By Product (Raw Materials, Instruments), By Workflow (Separation, Expansion), By Cell Type (T-cells, Stem Cells), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

細胞治療技術市場的成長和趨勢

根據 Grand View Research, Inc. 的一份新報告，全球細胞治療市場預計到 2030 年將達到 174.6 億美元，2025 年至 2030 年的複合年成長率為 17.84%。

市場受到對先進療法日益成長的需求的推動，特別是在癌症、自體免疫疾病和再生醫學領域。自動化、生物製程創新、增加研發投入以及支援性法規正在推動成長。各公司正在擴大製造能力和夥伴關係，以提高效率、可擴展性和產品開發，預計將進一步推動對細胞治療技術的需求。

COVID-19 疫情增加了研發投入、臨床試驗和對先進療法的需求，加速了細胞治療技術市場的發展。 COVID-19 疫情凸顯了再生醫學和免疫治療領域對自動化、高效製造和可擴展生產的需求，從而刺激了創新和產業成長。這些因素正在推動市場的成長，預計在預測期內市場將呈指數級成長。

CAR-T、TCR-T 和幹細胞療法等先進細胞療法的日益普及預計將進一步推動對細胞治療技術的需求。基因編輯、自動化和生物加工方面的創新正在提高效率、可擴展性和生產品質。隨著越來越多性化和再生療法核准，對專用設備、成分和製造解決方案的需求將持續成長。預計這些因素將在預測期內推動市場成長。

細胞治療技術的高成本可能會減緩未來幾年的市場成長。原料昂貴、製造工序複雜、法規嚴格，導致生產成本高。由於企業需要專門的設備、技術純熟勞工和先進的技術，這也會增加費用。有限的保險覆蓋範圍和定價挑戰可能會進一步限制採用。透過更好的流程、自動化和擴大生產規模來降低成本可能是未來成長的關鍵。

細胞治療技術市場報告重點

  • 按產品分類，消耗品部分在 2024 年佔據了 42.70% 的最大市場佔有率。這是因為它廣泛用於培養、擴增和處理細胞。研究、臨床測試和商業製造對試劑、生長因子和培養基的持續需求正在推動顯著的成長。另一方面，預計預測期內軟體將以最快的複合年成長率成長。
  • 根據工作流程，由於治療開發和製造對自動化和高效細胞分離技術的需求不斷成長，分離部分預計將引領市場並以最快的複合年成長率（2025-2030 年）成長。預計預測期內擴張部分將大幅成長。
  • 根據細胞類型，由於 CAR-T 和 TCR-T 療法在癌症、自體免疫疾病和感染疾病中的應用越來越多，以及基因編輯和細胞增殖技術的進步，T 細胞部分預計將佔據市場主導地位並以最快的複合年成長率（2025-2030 年）成長。預計預測期內幹細胞部分將大幅成長。
  • 根據最終用途，生物製藥和製藥公司部門在 2024 年佔據了市場主導地位，這歸因於對細胞療法研發的投資增加、對先進療法的需求不斷成長以及癌症、自體免疫疾病和再生療法的商業性製造能力的擴大。另一方面，預計預測期內 CMO 和 CRO 將以最快的複合年成長率成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 細胞治療技術市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 細胞治療技術市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第4章 細胞治療技術市場：產品評估及趨勢分析

  • 細分儀表板
  • 全球細胞治療技術市場產品趨勢分析
  • 2018 年至 2030 年全球細胞治療技術市場規模及趨勢分析（依產品分類）
  • 原料
    • 培養基
    • 血清
    • 細胞培養補充劑
    • 抗體
    • 試劑和緩衝液
    • 其他
  • 裝置
    • 細胞治療處理系統
    • 細胞培養系統
    • 細胞分選分離系統
    • 其他設備
    • 軟體
    • 耗材及配件

第 5 章細胞治療技術市場：按工作流程進行的估計和趨勢分析

  • 細分儀表板
  • 全球細胞治療技術市場工作流程變化分析
  • 2018 年至 2030 年全球細胞治療技術市場規模與趨勢分析（依工作流程）
  • 分離
  • 擴張
  • 血液成分分析
  • 灌裝-精加工
  • 冷凍保存
  • 其他

第6章細胞治療技術市場：按細胞類型估計和趨勢分析

  • 細分儀表板
  • 全球細胞治療技術市場細胞類型變異分析
  • 2018 年至 2030 年全球細胞治療技術市場規模及趨勢分析（依細胞類型）
  • T 細胞
  • 幹細胞
  • 其他細胞

第7章 細胞治療技術市場：按最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球細胞治療技術市場最終用途變化分析
  • 2018 年至 2030 年全球細胞治療技術市場規模及趨勢分析（依最終用途）
  • 生物製藥和生物技術公司
  • CMO 和 CRO
  • 其他

第 8 章 細胞治療技術市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024 年企業市場分析
  • 公司簡介/上市公司
    • Danaher Corporation
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza Group
    • Sartorius AG
    • Promega
    • BD
    • Miltenyi BIoTec
    • CellPort Software
    • Shimadzu
Product Code: GVR-4-68040-516-0

Cell Therapy Technologies Market Growth & Trends:

The global cell therapy technologies market size is anticipated to reach USD 17.46 billion by 2030, registering a CAGR of 17.84% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising demand for advanced treatments, especially in cancer, autoimmune diseases, and regenerative medicine. Automation, bioprocessing innovations, increasing R&D investments, and supportive regulations fuel growth. Companies are expanding manufacturing capabilities and partnerships to improve efficiency, scalability, and product development, which is further anticipated to fuel the demand for cell therapy technologies.

The COVID-19 pandemic accelerated the cell therapy technologies market by increasing R&D investments, clinical trials, and demand for advanced therapies. It highlighted the need for automation, efficient manufacturing, and scalable production in regenerative medicine and immune-based treatments, driving innovation and industry growth. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

The growing adoption of advanced cell therapies, including CAR-T, TCR-T, and stem cell treatments, is expected to drive further demand for cell therapy technologies. Innovations in gene editing, automation, and bioprocessing are enhancing efficiency, scalability, and production quality. As more personalized and regenerative treatments gain approval, the need for specialized equipment, raw materials, and manufacturing solutions will continue to rise. These factors are thus projected to impel the market's growth over the forecast period.

The high cost of cell therapy technologies could slow market growth in the coming years. Expensive raw materials, complex manufacturing, and strict regulations make production costly. Companies also need specialized equipment, skilled workers, and advanced technology, adding to expenses. Limited insurance coverage and pricing challenges may further restrict adoption. Reducing costs through better processes, automation, and scaling up production will be key for future growth.

Cell Therapy Technologies Market Report Highlights:

  • Based on products, the consumables segment held the largest market share of 42.70% in 2024 due to their wide use in cell culture, expansion, and processing. The recurring demand for reagents, growth factors, and media in research, clinical trials, and commercial production has driven significant growth. On the other hand, software is expected to grow at the fastest CAGR over the forecast period
  • Based on workflow, the separation segment is expected to lead the market and grow at the fastest CAGR (2025-2030) due to increasing demand for automated, efficient cell isolation techniques in therapy development and manufacturing. The expansion segment is expected to grow significantly over the forecast period
  • Based on cell-type, the T-cells segment is expected to dominate the market and grow at the fastest CAGR (2025-2030) due to increasing adoption of CAR-T and TCR-T therapies for cancer, autoimmune diseases, and infectious diseases, along with advancements in gene editing and cell expansion technologies. The stem cells segment is expected to grow significantly over the forecast period.
  • Based on end use, the biopharmaceutical & pharmaceutical companies segment dominated the market in 2024 due to increasing investments in cell therapy R&D, growing demand for advanced treatments, and expanding commercial manufacturing capabilities for cancer, autoimmune, and regenerative therapies. On the other hand, CMOs & CROs are expected to grow at the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Workflow
    • 1.2.3. Cell Type
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Therapy Technologies Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in Cell-Based Therapies
      • 3.2.1.2. Increased Funding and Investment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Costs and Manufacturing Challenges
  • 3.3. Cell Therapy Technologies Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Therapy Technologies Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell Therapy Technologies Market Product Movement Analysis
  • 4.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Raw Materials
    • 4.4.1. Raw materials market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Media
      • 4.4.2.1. Media market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Sera
      • 4.4.3.1. Sera market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cell Culture Supplements
      • 4.4.4.1. Cell Culture Supplements market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Antibodies
      • 4.4.5.1. Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Reagents & Buffers
      • 4.4.6.1. Reagents & buffers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Cell Therapy Processing Systems
      • 4.5.2.1. Cell therapy processing systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Cell Culture Systems
      • 4.5.3.1. Cell culture systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Cell Sorting & Separation Systems
      • 4.5.4.1. Cell sorting & separation systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Other Instruments
      • 4.5.5.1. Other instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Software
      • 4.5.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Consumables & Accessories
      • 4.5.7.1. Consumables & accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cell Therapy Technologies Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell Therapy Technologies Market Dosage Workflow Movement Analysis
  • 5.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Separation
    • 5.4.1. Separation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Expansion
    • 5.5.1. Expansion market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Apheresis
    • 5.6.1. Apheresis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Fill- Finish
    • 5.7.1. Fill- finish market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Cryopreservation
    • 5.8.1. Cryopreservation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cell Therapy Technologies Market: Cell Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cell Therapy Technologies Market Cell Type Movement Analysis
  • 6.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Cell Type, 2018 to 2030 (USD Million)
  • 6.4. T-cells
    • 6.4.1. T-cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Stem Cells
    • 6.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other Cells
    • 6.6.1. Other cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cell Therapy Technologies Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Cell Therapy Technologies Market End Use Movement Analysis
  • 7.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Biopharmaceutical & Biotechnology Companies
    • 7.4.1. Biopharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. CMOs & CROs
    • 7.5.1. CMOs & CROs market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cell Therapy Technologies Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Danaher Corporation
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Lonza Group
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Sartorius AG
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Promega
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. BD
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Miltenyi Biotec
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. CellPort Software
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Shimadzu
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell therapy technologies market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 6 Global cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 North America cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 11 North America cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 14 U.S. cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 15 U.S. cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Canada cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 19 Canada cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Mexico cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 23 Mexico cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Europe cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 28 Europe cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Germany cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 32 Germany cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 33 UK cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 34 UK cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 UK cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 36 UK cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 38 France cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 France cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 40 France cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Italy cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 44 Italy cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Spain cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 48 Spain cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Denmark cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 52 Denmark cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
  • Table 55 Sweden cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
  • Table 56 Sweden cell therapy technologies market, by end use, 2018 - 2030 (USD Million
  • Table 57 Norway cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
  • Table 59 Norway cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
  • Table 60 Norway cell therapy technologies market, by end use, 2018 - 2030 (USD Million
  • Table 61 Asia Pacific cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
  • Table 64 Asia Pacific cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
  • Table 65 Asia Pacific cell therapy technologies market, by end use, 2018 - 2030 (USD Million
  • Table 66 China cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 67 China cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 China cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 69 China cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 71 Japan cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 Japan cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 73 Japan cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 75 India cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 India cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 77 India cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Korea cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Korea cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 South Korea cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 81 South Korea cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Australia cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 83 Australia cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Australia cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 85 Australia cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 88 Thailand cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 89 Thailand cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Latin America cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 94 Latin America cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Brazil cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 98 Brazil cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Argentina cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 102 Argentina cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 MEA cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 107 MEA cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Africa cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 111 South Africa cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 118 UAE cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 119 UAE cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Kuwait cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait cell therapy technologies market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cell therapy technologies market: Market outlook
  • Fig. 5 Cell therapy technologies market: Segment outlook
  • Fig. 6 Cell therapy technologies market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cell therapy technologies market driver impact
  • Fig. 9 Cell therapy technologies market restraint impact
  • Fig. 10 Cell therapy technologies market: Product outlook and key takeaways
  • Fig. 11 Cell therapy technologies market: Product movement analysis
  • Fig. 12 Raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sera market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Cell culture supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Reagents & buffers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cell therapy processing systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Cell culture systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Cell sorting & separation systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Consumables & accessories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cell therapy technologies market: Workflow outlook and key takeaways
  • Fig. 27 Cell therapy technologies market: Workflow movement analysis
  • Fig. 28 Separation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Expansion market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 30 Apheresis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Fill- finish market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Cryopreservation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Cell therapy technologies market: Cell type outlook and key takeaways
  • Fig. 35 Cell therapy technologies market: Cell type movement analysis
  • Fig. 36 T-cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Stem cells market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 38 Other cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Cell therapy technologies market: End use outlook and key takeaways
  • Fig. 40 Cell therapy technologies market: End use movement analysis
  • Fig. 41 Biopharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 CMOs & CROs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 44 Global cell therapy technologies market: Regional outlook and key takeaways
  • Fig. 45 Global cell therapy technologies market: Regional movement analysis
  • Fig. 46 North America cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Europe cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Germany cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Japan cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)